MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated